App 3Y change to interests on lapse of options - Collier
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
INVION LIMITED
ABN
76 094 730 417
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
DR GREG COLLIER
Date of last notice
11 December 2015
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Change to direct holding.
Indirect holdings are Beacon Super Fund Pty
Ltd ATF Beacon Super Fund of which Dr
Collier is a director and beneficiary; Barwon
Biotechnology Pty Ltd of which Dr Collier is
a director and shareholder; and Fusion
Biosciences Pty Ltd of which Dr Collier is a
director.
Date of change
9 November 2017
Total No. of securities held prior to change
18,080,432 fully
(indirectly held).
paid
ordinary
shares
10,000,000 Share Options with an exercise
price of $0.10 and an expiry date of
9 November 2017 (directly held).
Class
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Lapse of unlisted share options
Appendix 3Y
Change of Director’s Interest Notice
Number acquired
Nil
Number disposed
Nil disposed. Lapse of unlisted share options.
Value/Consideration
n/a
Total No. of securities held after change
18,080,432 fully
(indirectly held).
Nature of change
Lapse of unlisted share options.
Note: If consideration is non-cash, provide details and estimated
valuation
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
paid
ordinary
shares
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
n/a
Nature of interest
n/a
Name of registered holder
(if issued securities)
n/a
Date of change
n/a
No. and class of securities to which n/a
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
n/a
Interest disposed
n/a
Value/Consideration
n/a
Interest after change
n/a
Note: If consideration is non-cash, provide details
and an estimated valuation
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
Part 3 – +Closed period
Were the interests in the securities or contracts detailed n/a
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade n/a
to proceed during this period?
If prior written clearance was provided, on what date was this n/a
provided?
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Share your feedback
Discover